HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GOP Health Care Proposal Cuts Rx Requirement To Buy OTCs With Pre-Tax Savings

This article was originally published in The Tan Sheet

Executive Summary

Repealing the Affordable Care Act “takes the critical step of restoring the ability to use funds” for OTC drugs “as a qualified medical expense,” say GOP leaders. The proposed legislation also would eliminate a tax on Rx drugs and medical devices that industry negotiated in the creation of ACA.

You may also be interested in...



Unfettered OTC Purchasing With Pre-Tax Savings Tops CHPA Goals In 2015

CHPA is optimistic 2015 is the year “common sense” will restore OTC eligibility for health spending accounts. Speaking on the group’s priorities, President and CEO Scott Melville said CHPA will work to improve the OTC monograph system and to curb cough medicine abuse.

$8 Billion And Counting: Pharma Paying Its ACA Taxes

HHS OIG report shows pharma industry fee is being paid, albeit with a few bumps along the way.

Supreme Court Routes OTC Health Savings Battle Back To Congress

The future of the provision requiring prescriptions for OTC purchases with health savings accounts is back in Congress’ hands. But with elections pending, lawmakers will likely stay away from legislation that would change, rather than repeal, the ACA.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel